Fallopian Tube Cancer

Common Name(s)

Fallopian Tube Cancer

Fallopian tube cancer is a very rare form of cancer with only 1,500 to 2,000 cases reported each year in the United States. However, a number of cancers start in other parts of the body and spread to the fallopian tubes, called secondary fallopian tube cancers. Some symptoms include abnormal vaginal bleeding, abnormal vaginal discharge, abdominal pain, and feeling a mass in the abdomen (belly) or pelvis. A female pelvic exam can assist in the diagnosis of this condition by evaluating the size and shape of the uterus, vagina, ovaries, fallopian tubes, bladder and rectum. A blood test can also be performed to check the levels of a certain protein called CA125, which may be used to diagnose fallopian tube cancer. Treatment usually involves surgery and chemotherapy, depending on age, desire to have children, and the type and stage of the tumor.

Source: Advocacy organizations associated with the condition.

 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Fallopian Tube Cancer" for support, advocacy or research.

There are currently no organizations listed in Disease InfoSearch that support this condition. Create a listing.

 

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
Top

How do you compare to others with this condition?

Privately answer questions about your health. Let resources, you select, come to you.

Anonymously share and see how your answers compare with others with this condition while privately providing key pieces of information to medical researchers, disease advocacy groups, and others ONLY YOU select to help speed up cures and better alternatives.

 
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Fallopian Tube Cancer" for support, advocacy or research.

There are currently no organizations listed in Disease InfoSearch that support this condition. Create a listing.

 

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
 
 
Top

Scientific Literature

Articles from the PubMed Database

Research articles describe the outcome of a single study. They are the published results of original research.
The terms "Fallopian Tube Cancer" returned 60 free, full-text research articles on human participants. First 3 results:

A phase I trial of pegylated liposomal doxorubicin (PLD), carboplatin, bevacizumab and veliparib in recurrent, platinum-sensitive ovarian, primary peritoneal, and fallopian tube cancer: An NRG Oncology/Gynecologic Oncology Group study.
 

Author(s): Lisa M Landrum, William E Brady, Deborah K Armstrong, Kathleen N Moore, Paul A DiSilvestro, David M O'Malley, Meaghan E Tenney, Peter G Rose, Paula M Fracasso

Journal: Gynecol. Oncol.. 2016 Feb;140(2):204-9.

 

To determine the maximum tolerated dose (MTD) and dose-limiting toxicities (DLTs) of veliparib combined with PLD and carboplatin (CD) in patients with recurrent, platinum-sensitive epithelial ovarian cancer. To determine the tolerability at the MTD combined with bevacizumab.

Last Updated: 24 Jan 2016

Go To URL
Cognitive function during and six months following chemotherapy for front-line treatment of ovarian, primary peritoneal or fallopian tube cancer: An NRG oncology/gynecologic oncology group study.
 

Author(s): Lisa M Hess, Helen Q Huang, Alexandra L Hanlon, William R Robinson, Rhonda Johnson, Setsuko K Chambers, Robert S Mannel, Larry Puls, Susan A Davidson, Michael Method, Shashikant Lele, Laura Havrilesky, Tina Nelson, David S Alberts

Journal: Gynecol. Oncol.. 2015 Dec;139(3):541-5.

 

Changes in cognitive function have been identified in and reported by many cancer survivors. These changes have the potential to impact patient quality of life and functional ability. This prospective longitudinal study was designed to quantify the incidence of change in cognitive ...

Last Updated: 15 Dec 2015

Go To URL
Fallopian Tube Ligation or Salpingectomy as Means for Reducing Risk of Ovarian Cancer.
 

Author(s): J Brian Szender, Shashikant B Lele

Journal:

 

Last Updated: 22 Sep 2015

Go To URL

Reviews from the PubMed Database

Review articles summarize what is currently known about a disease. They discuss research previously published by others.
The terms "Fallopian Tube Cancer" returned 5 free, full-text review articles on human participants. First 3 results:

FIGO's staging classification for cancer of the ovary, fallopian tube, and peritoneum: abridged republication.
 

Author(s): Jaime Prat,

Journal: J Gynecol Oncol. 2015 Apr;26(2):87-9.

 

Last Updated: 15 Apr 2015

Go To URL
Primary fallopian tube cancer: domestic data and up-to-date review.
 

Author(s): Huann-Cheng Horng, Sen-Wen Teng, Ben-Shian Huang, Hsu-Dong Sun, Ming-Shyen Yen, Peng-Hui Wang, Kuan-Hao Tsui, Kuo-Chang Wen, Yi-Jen Chen, Chi-Mu Chuang, Hsiang-Tai Chao, Wen-Hsun Chang

Journal: Taiwan J Obstet Gynecol. 2014 Sep;53(3):287-92.

 

Primary fallopian tube carcinoma (PFTC) is a rare gynecological malignancy with the following characteristics: its preoperative diagnosis is easy to miss or delay because of a lack of specific symptoms and signs; it is difficult to distinguish from serous epithelial ovarian cancer ...

Last Updated: 7 Oct 2014

Go To URL
The role of the fallopian tube in the origin of ovarian cancer.
 

Author(s): Britt K Erickson, Michael G Conner, Charles N Landen

Journal: Am. J. Obstet. Gynecol.. 2013 Nov;209(5):409-14.

 

Advanced cases of epithelial ovarian, primary peritoneal, and primary tubal malignancies have a relatively poor prognosis and collectively remain the most deadly of all gynecologic malignancies. Although traditionally thought of as one disease process, ongoing research suggests that ...

Last Updated: 11 Nov 2013

Go To URL
 
 
Top

Symptoms, Diagnosis, and Treatment

There are currently no related results available in Genetics Home Reference.

There are currently no related results available in GeneReviews.

There are currently no related results available in Genetic Testing Registry.

 
 
Top

Clinical Trial Information This information is provided by ClinicalTrials.gov

p53 Gene in Treatment of Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, and Primary Peritoneal Cancer
 

Status: Not yet recruiting

Condition Summary: Ovarian Epithelial Cancer; Fallopian Tube Cancer; Primary Peritoneal Cancer

 

Last Updated: 30 Apr 2015

Go to URL
Carboplatin and Gemcitabine Hydrochloride With or Without ATR Kinase Inhibitor VX-970 in Treating Patients With Recurrent and Metastatic Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
 

Status: Not yet recruiting

Condition Summary: High Grade Ovarian Serous Adenocarcinoma; Ovarian Endometrioid Tumor; Recurrent Fallopian Tube Carcinoma; Recurrent Ovarian Carcinoma; Recurrent Primary Peritoneal Carcinoma; Stage IV Fallopian Tube Cancer; Stage IV Ovarian Cancer; Stage IV Primary Peritoneal Cancer

 

Last Updated: 21 Jun 2016

Go to URL
A Phase 1b Study of Weekly Paclitaxel And Oral Ricolinostat For The Treatment Of Recurrent Platinum Resistant Ovarian, Primary Peritoneal, Or Fallopian Tube Cancer
 

Status: Not yet recruiting

Condition Summary: Ovarian Cancer; Fallopian Tube Cancer; Primary Peritoneal Cancer

 

Last Updated: 20 Jan 2016

Go to URL